BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9072217)

  • 1. [Beta-blockers in the treatment of open-angle glaucoma].
    Potocký M; Vodrázková E
    Cesk Slov Oftalmol; 1996 Nov; 52(6):399-402. PubMed ID: 9072217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative evaluation of the hypotensive effectiveness of beta blockers].
    Erichev VP
    Vestn Oftalmol; 1992; 108(3):25-7. PubMed ID: 1362302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Betoptic, a new possibility in the treatment of glaucoma].
    Potocký M; Vodrázková E
    Cesk Oftalmol; 1992 Jul; 48(4):306-9. PubMed ID: 1394532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta adrenergic blocking agents for open-angle glaucoma.
    Lee ME
    J Am Optom Assoc; 1988 Jul; 59(7):567-71. PubMed ID: 2900260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of the use of betoptik (betaxolol) in the treatment of primary glaucoma].
    Ermakova VN; Buromskaia AM; Davydova NG; Kolomoĭtseva EM
    Vestn Oftalmol; 1992; 108(1):12-4. PubMed ID: 1585527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two new beta-blockers for glaucoma.
    Med Lett Drugs Ther; 1986 Apr; 28(712):45-6. PubMed ID: 2870417
    [No Abstract]   [Full Text] [Related]  

  • 9. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levobunolol HCl--a beta-blocker produced by the firm Allergan].
    Síp L; Růzicková E
    Cesk Oftalmol; 1992 Oct; 48(5):370-3. PubMed ID: 1486629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of 0.85% RS-timolol and 0.5% S-timolol on intraocular pressure and systemic arterial blood pressure, heart rate, ECG, expiratory capacity in patients with ocular hypertension and primary open-angle glaucoma].
    Czechowicz-Janicka K; Staszkiewicz J; Strzałkowska M; Krajewska M; Popiołek B; Christman A
    Klin Oczna; 1999; 101(5):333-7. PubMed ID: 10714069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vistagan-Liquifilm in the treatment of simple glaucoma].
    Szymankiewiczowa S
    Klin Oczna; 1989 Jun; 91(6):163-4. PubMed ID: 2576678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epidemiologic and tonometric results of a multicenter study of 5,872 patients with ocular hypertension or open-angle glaucoma treated with betaxolol].
    Bourgeois H
    Ophtalmologie; 1990; 4(4):323-5. PubMed ID: 2263381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker eye drops.
    Nurs Times; 2006 May 30-Jun 5; 102(22):29. PubMed ID: 16764382
    [No Abstract]   [Full Text] [Related]  

  • 16. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy and safety of timoptic depot in hypotensive therapy of glaucoma].
    Erichev VP; Iakubova LV
    Vestn Oftalmol; 1998; 114(1):8-9. PubMed ID: 9584629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Timolol, betaxolol and befunolol in the treatment of glaucoma. Study of their bronchopulmonary effects].
    Pecori-Giraldi J; Collini S; Planner-Terzaghi A; Arrico L; Grechi G
    Fortschr Ophthalmol; 1988; 85(3):235-8. PubMed ID: 2905321
    [No Abstract]   [Full Text] [Related]  

  • 20. Timolol maleate 0.5% versus timolol maleate in gel forming solution 0.5% (Timolol GFS) in open angle glaucoma in India. Preliminary safety and efficacy study.
    Kumar H; Sudan R; Sethi HS; Sony P
    Indian J Ophthalmol; 2002 Mar; 50(1):21-3. PubMed ID: 12090082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.